Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas

Texture Feature Ratios from Relative CBV Maps of Perfusion MRI Are Associated with Patient Survival in Glioblastoma

(2015) J. Lee et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

MR Imaging–Based Analysis of Glioblastoma Multiforme: Estimation ofIDH1Mutation Status

(2015) K. Yamashita et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma

(2015) Shakti H. Ramkissoon et al.   NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

(2015) Quinn T. Ostrom et al.   NEURO-ONCOLOGY

Somatic mutations associated with MRI-derived volumetric features in glioblastoma

(2015) David A. Gutman et al.   NEURORADIOLOGY

A Generic Support Vector Machine Model for Preoperative Glioma Survival Associations

(2015) Kyrre E. Emblem et al.   RADIOLOGY

Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas

(2015) Jane B. Cryan et al.   Oncotarget

Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas

(2014) Yukihiko Sonoda et al.   Brain Tumor Pathology

Improving tumour heterogeneity MRI assessment with histograms

(2014) N Just   BRITISH JOURNAL OF CANCER

Radiogenomics and Imaging Phenotypes in Glioblastoma: Novel Observations and Correlation with Molecular Characteristics

(2014) Benjamin M. Ellingson   Current Neurology and Neuroscience Reports

High Throughput Tools to Access Images from Clinical Archives for Research

(2014) Shawn N. Murphy et al.   JOURNAL OF DIGITAL IMAGING

Evaluation of the microenvironmental heterogeneity in high-grade gliomas with IDH1/2 gene mutation using histogram analysis of diffusion-weighted imaging and dynamic-susceptibility contrast perfusion imaging

(2014) Seunghyun Lee et al.   JOURNAL OF NEURO-ONCOLOGY

Recurrent glioblastoma: Volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab

(2013) Raymond Y. Huang et al.   CANCER

RADIOLOGY

(2013) Y. Arakawa et al.   NEURO-ONCOLOGY

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection

(2013) Jason Beiko et al.   NEURO-ONCOLOGY

Survival Analysis of Patients with High-Grade Gliomas Based on Data Mining of Imaging Variables

(2012) E.I. Zacharaki et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Probabilistic Radiographic Atlas of Glioblastoma Phenotypes

(2012) B.M. Ellingson et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma

(2012) J.A. Carrillo et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas

(2012) Changho Choi et al.   NATURE MEDICINE

Towards MIB-1 and p53 detection in glioma magnetic resonance image: a novel computational image analysis method

(2012) Chenbin Liu et al.   PHYSICS IN MEDICINE AND BIOLOGY

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy

(2011) Whitney B. Pope et al.   JOURNAL OF NEURO-ONCOLOGY

High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing

(2011) Nikhil Wagle et al.   Cancer Discovery

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

(2010) Christian Hartmann et al.   ACTA NEUROPATHOLOGICA

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis

(2010) Philippe Metellus et al.   ACTA NEUROPATHOLOGICA

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children’s Oncology Group

(2010) Ian F. Pollack et al.   CHILDS NERVOUS SYSTEM

Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease

(2010) Barbara S. Paugh et al.   JOURNAL OF CLINICAL ONCOLOGY

Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas

(2010) Benjamin M. Ellingson et al.   JOURNAL OF NEURO-ONCOLOGY

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas

(2010) C. Houillier et al.   NEUROLOGY

Cancer-associated IDH mutations: biomarker and therapeutic opportunities

(2010) K E Yen et al.   ONCOGENE

IDH mutations in glioma and acute myeloid leukemia

(2010) Lenny Dang et al.   TRENDS IN MOLECULAR MEDICINE

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

(2009) Christian Hartmann et al.   ACTA NEUROPATHOLOGICA

Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme

(2009) Evangelia I. Zacharaki et al.   MAGNETIC RESONANCE IN MEDICINE

An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging

(2009) Sylvia Drabycz et al.   NEUROIMAGE

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathway Analysis of Single-Nucleotide Polymorphisms Potentially Associated with Glioblastoma Multiforme Susceptibility Using Random Forests

(2008) J. S. Chang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The Use of Magnetic Resonance Imaging to Noninvasively Detect Genetic Signatures in Oligodendroglioma

(2008) R. Brown et al.   CLINICAL CANCER RESEARCH

Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM

(2008) Forrest W. Crawford et al.   JOURNAL OF NEURO-ONCOLOGY

Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy

(2008) Suja Saraswathy et al.   JOURNAL OF NEURO-ONCOLOGY

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE